Michael J. Fucci has recently been appointed to the Board of Directors at Acadia Healthcare Company, Inc., a notable addition that signals the company’s commitment to enhancing its governance and strategic direction. Since October 2020, Fucci has brought a wealth of experience and expertise to Acadia Healthcare, particularly in the context of human resource transformation and risk management.

Before his tenure at Acadia, Fucci served as Chairman Emeritus of Deloitte U.S., a role he held until his retirement in September 2020. Detailed on Crunchbase, his extensive career at Deloitte spanned several key leadership positions, including Executive Chairman from 2015 to 2019 and Chief Operating Officer of Deloitte Consulting from 2009 to 2015.

In his capacity as a director at Acadia Healthcare, Fucci joins a board that has been expanded to nine members, eight of whom are independent, reinforcing the company’s governance structure. On Acadia’s Board of Directors page, Reeve B. Waud, Chairman of Acadia’s Board of Directors, expressed confidence in Fucci’s ability to contribute significantly to the company’s growth strategy.

Acadia Healthcare, headquartered in Franklin, Tennessee, is a leading provider of behavioral healthcare services. As the demand for behavioral health services continues to rise, particularly in the wake of the COVID-19 pandemic, Fucci’s appointment comes at a critical time for the organization.

Fucci’s background in risk mitigation and governance will be invaluable as Acadia aims to deliver long-term value for its stockholders while maintaining high standards in patient care. As noted on F6S, his role will extend beyond traditional governance, involving active participation in shaping Acadia’s strategic direction during a time of unprecedented change in the healthcare landscape.

In summary, Mike Fucci’s addition to Acadia Healthcare’s Board of Directors is not merely a strategic move but a pivotal step toward reinforcing the company’s commitment to excellence in behavioral healthcare. His extensive experience in leadership roles, particularly at Deloitte, will undoubtedly provide Acadia with valuable insights as it navigates the complexities of the healthcare industry.